Cambridge, MA, United States
Dec 31, 2020
**MEMBERS ONLY**SIGN UP NOW***., Inc., a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. **MEMBERS ONLY**SIGN UP NOW***. is a high growth company and is listed on NASDAQ (CUE). The company is located in Cambridge, Massachusetts in the heart of the life sciences corridor.
**MEMBERS ONLY**SIGN UP NOW***. is building a world-class team of highly motivated, dedicated scientists to help us advance our research and development programs. The company culture is fast-paced and committed to scientific excellence, innovation, and teamwork.